Ultragenyx pharmaceutical inc. (RARE)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Assets
Current assets:
Cash and cash equivalents

298,190

433,584

122,577

131,337

269,712

113,432

82,956

110,854

226,730

100,488

60,407

90,751

159,501

161,120

142,280

55,069

70,763

93,569

166,686

52,351

178,040

24,324

53,387

17,452

55,447

7,427

Short-term investments

365,088

321,646

404,481

486,949

445,604

346,274

420,142

436,278

314,616

134,005

310,659

308,897

265,689

219,028

254,150

336,734

341,092

343,428

281,697

273,678

164,526

163,163

147,807

135,819

109,950

45,950

Receivable related to Daiichi Sankyo license agreement

125,550

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, net

29,327

32,844

23,121

20,901

15,628

12,740

9,155

17,425

3,671

5,172

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

11,375

11,546

14,138

13,632

10,948

7,065

5,556

3,342

2,068

757

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

542

-

461

461

271

1,411

1,411

1,482

1,291

150

-

1,071

1,071

-

-

-

-

-

Prepaid expenses and other current assets

64,788

51,397

49,169

46,612

44,995

42,858

49,671

36,844

33,953

29,161

19,376

19,685

19,224

20,136

18,944

17,799

17,088

13,060

12,324

9,430

6,877

5,929

5,547

4,945

4,239

1,848

Total current assets

894,318

851,017

613,486

699,431

786,887

522,369

567,480

604,743

581,580

269,583

390,903

419,794

444,685

401,695

416,785

411,084

430,234

450,207

460,707

336,530

350,514

193,416

206,741

158,216

169,636

55,225

Property and equipment, net

47,596

44,348

31,877

25,317

21,696

20,046

19,828

20,858

20,830

21,837

16,030

16,405

16,517

17,055

18,226

17,054

13,418

7,373

6,285

4,772

3,514

3,033

2,621

2,497

1,777

1,325

Investment in Arcturus equity securities

35,420

27,752

26,333

24,167

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

1,931

-

1,805

1,805

1,996

2,076

2,076

2,346

2,537

2,135

912

912

1,031

744

744

744

744

451

Long-term investments

41,711

5,174

-

-

-

-

-

-

29,907

9,975

24,964

57,802

80,862

117,963

76,211

50,021

75,932

99,259

133,492

-

-

-

-

-

-

-

Right-of-use assets

35,827

30,328

31,711

33,356

23,024

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

129,000

129,000

129,020

129,069

129,086

129,223

130,232

132,776

137,122

141,545

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

44,406

44,406

44,406

44,406

44,406

44,406

44,406

44,406

44,406

44,406

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

4,862

3,471

3,111

3,181

2,660

3,514

3,199

3,239

1,574

3,407

1,345

1,736

1,762

1,837

1,868

1,446

2,063

595

734

790

781

774

825

1,129

550

2,648

Total assets

1,233,140

1,135,496

879,944

958,927

1,007,759

719,558

765,145

806,022

817,350

490,753

435,047

497,542

545,822

540,626

515,166

481,951

524,184

559,569

602,130

343,004

355,840

197,967

210,931

162,586

172,707

59,649

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

14,405

12,871

13,460

8,743

12,664

12,275

8,198

10,314

7,569

8,886

9,288

11,876

8,345

5,364

6,616

6,954

6,012

2,942

4,422

10,171

5,755

4,857

4,161

3,590

3,495

1,437

Accrued liabilities

67,719

83,194

69,557

59,264

48,957

62,450

58,483

55,735

49,291

62,128

54,278

50,130

42,773

54,554

43,487

24,714

23,565

24,784

20,148

12,716

8,398

7,575

6,831

5,278

3,238

4,406

Short-term contract liability

107,247

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term lease liabilities

7,487

7,235

7,290

6,999

5,259

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rentcurrent portion

-

-

-

-

-

-

-

-

723

-

695

669

637

341

328

315

303

192

163

155

90

85

80

75

78

78

Total current liabilities

196,858

103,300

90,307

75,006

66,880

74,725

66,681

66,049

57,583

71,014

64,261

62,675

51,755

60,259

50,431

31,983

29,880

27,918

24,733

23,042

14,243

12,517

11,072

8,943

6,811

5,921

Long-term contract liability

38,036

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term lease liabilities

34,958

29,757

31,206

32,968

22,984

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liabilities

33,306

33,306

31,166

31,166

31,166

31,166

31,166

31,166

31,166

31,166

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liability related to the sale of future royalties

320,836

315,369

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,419

Other liabilities

-

-

-

-

-

4,759

4,702

4,836

4,944

5,119

5,228

5,414

5,589

6,393

8,845

6,073

4,480

561

634

684

478

505

533

560

182

200

Total liabilities

623,994

481,732

152,679

139,140

121,030

110,650

102,549

102,051

93,693

107,299

69,489

68,089

57,344

66,652

59,276

38,056

34,360

28,479

25,367

23,726

14,721

13,022

11,605

9,503

6,993

9,540

Commitments and contingencies (Notes 9 and 16)

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

0

0

0

0

0

0

0

Stockholders’ equity:
Preferred stock — 25,000,000 shares authorized; nil outstanding as of March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock — 250,000,000 shares authorized; 59,488,873 and 57,838,220 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

59

58

58

58

57

51

51

50

50

44

42

42

42

41

40

39

39

39

39

36

36

32

32

30

30

4

Additional paid-in capital

2,162,667

2,086,863

2,066,483

2,045,685

2,013,859

1,639,773

1,605,412

1,559,722

1,526,972

1,221,762

1,123,861

1,105,348

1,087,028

1,003,561

915,084

837,943

827,109

816,578

806,202

509,658

501,597

324,128

321,714

259,555

258,599

-

Accumulated other comprehensive loss

-1,545

-147

-71

255

-148

-633

-410

-654

-946

-5,680

-7,404

-4,223

231

905

12

252

92

-868

-39

-209

-94

-174

-118

-48

-46

11

Accumulated deficit

-1,552,035

-1,433,010

-1,339,205

-1,226,211

-1,127,039

-1,030,283

-942,457

-855,147

-802,419

-832,672

-750,941

-671,714

-598,823

-530,533

-459,246

-394,339

-337,416

-284,659

-229,439

-190,207

-160,420

-139,041

-122,302

-106,454

-92,869

-74,836

Total stockholders’ equity

609,146

653,764

727,265

819,787

886,729

608,908

662,596

703,971

723,657

383,454

365,558

429,453

488,478

473,974

455,890

443,895

489,824

531,090

576,763

319,278

341,119

184,945

199,326

153,083

165,714

-74,821

Total liabilities and stockholders’ equity

1,233,140

1,135,496

879,944

958,927

1,007,759

719,558

765,145

806,022

817,350

490,753

435,047

497,542

545,822

540,626

515,166

481,951

524,184

559,569

602,130

343,004

355,840

197,967

210,931

162,586

172,707

59,649